ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

GOVXW GeoVax Labs Inc

0.0599
-0.0001 (-0.17%)
取引時間後
最終更新日: 05:02:00
15分遅延
名称 銘柄コード 市場 種別
GeoVax Labs Inc GOVXW NASDAQ Equity Warrant
  前日比 前日比 % 現在値 時刻
-0.0001 -0.17% 0.0599 05:02:00
始値 安値 高値 終値 前日終値
0.0599 0.0599 0.0599 0.0599 0.06
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/2505:04EDGAR2Form 8-K - Current report
2024/5/2405:07EDGAR2Form 8-K - Current report
2024/5/2206:23EDGAR2Form 8-K - Current report
2024/5/2201:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/5/1605:03EDGAR2Form 8-K - Current report
2024/5/1506:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/1506:09EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/1506:08EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/1506:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/1505:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/4/0501:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
2024/3/2822:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
2024/3/1222:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
2024/3/0623:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
2024/3/0106:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
2024/2/2223:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
2024/2/1923:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
2024/2/1323:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
2024/2/0623:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
2024/1/2923:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
2024/1/0823:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
2024/1/0423:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
2024/1/0323:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
2023/12/2723:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
2023/12/1923:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
2023/12/0106:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
2023/11/2923:00GLOBEGeoVax to Participate in Upcoming December Investor Events
2023/11/2823:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
2023/11/1423:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
2023/11/0906:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
2023/10/3122:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
2023/10/3022:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
2023/10/2522:00GLOBEGeoVax to Participate in Upcoming November Investor and..
2023/10/2422:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
2023/10/0922:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
2023/10/0522:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
2023/9/2722:00GLOBEGeoVax to Participate in Upcoming October Investor and..
2023/9/2622:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
2023/9/2022:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
2023/9/1922:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
2023/9/1222:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
2023/9/1122:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
2023/8/3122:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
2023/8/2822:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
2023/8/1022:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
2023/8/1005:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
2023/7/2622:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
2023/7/2422:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
2023/7/2022:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
2023/7/1022:00GLOBEGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS..

最近閲覧した銘柄

Delayed Upgrade Clock